1. Medtech Insight

Minute Insight: New Butterfly Network CEO Has Tough Job Ahead

 
• By Barnaby Pickering and Reed Miller

The handheld ultrasound company made a loss last quarter, but secured FDA authorization for a new ultrasound software and named new leadership.

Minute Insight
• Source: Informa/Alamy

Butterfly Network’s latest earnings failed to impress investors as the company made a loss of $33.5m on revenue of $15.5m in the first quarter of 2023.

The handheld ultrasound technology company is the latest example of a company with an potentially important technology whose stock has fallen flat after going public through a special purpose acquisition company (SPAC)

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Minute Insights

More from Medtech Insight

Roche To Localize CGM Manufacturing in US with $550M Indiana Site Investment

 
• By Shubham Singh

Roche’s Indianapolis site currently produces 5.2 billion Accu-Chek test strips annually and supports distribution to 53 countries. The new CGM line will add to an already diversified operational footprint, which includes R&D, laboratories, manufacturing, and IT services.

What’s A Diagnostic? WHO Wants To Know

 
• By Elizabeth Orr

The World Health Organization is seeking input from stakeholders to create an official definition of the term ‘diagnostics.’ This initiative follows a 2023 resolution aimed at enhancing global diagnostics capacity; the definition, it is hoped, will help drive the creation of effective health policies. Comments will be accepted until 23 May.

‘Help Us Deregulate’: RFK Announces RFI For Trimming Government Health Agencies

 
• By Brian Bossetta

HHS Secretary Robert F. Kennedy, Jr. is asking the public to help cut waste across the government’s health agencies. Kennedy announced a 60-day comment period allowing the public to take part in a broader federal initiative to reduce regulations and increase transparency.